Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.50 EUR
224.49 M EUR
2.28 B EUR
348.76 M
About ASPEN PHARMACARE HLDGS LTD
Sector
CEO
Stephen Bradley Saad
Headquarters
Durban
Website
Founded
1850
ISIN
ZAE000066692
FIGI
BBG000BPJ037
Aspen Pharmacare Holdings Ltd. manufactures and supplies branded and generic pharmaceutical products. It operates through the Commercial Pharmaceuticals and Manufacturing segments. The Commercial Pharmaceuticals segment consists of the following business sub segments: Sterile Focused Brands, which includes the Anaesthetics and Thrombosis portfolios; and Regional Brands, which are products that are managed on a regional basis. The Manufacturing segment focuses on the following business sub segments: Active Pharmaceutical Ingredients, which involved in API Chemicals business and non-heparin biochemical API business; Heparin, which refers to the full value chain contribution from all heparin containing products; FDF Steriles, which includes all FDF sterile sales; and FDF Other, which consists of all non-sterile FDF products. The company was founded by Michael Guy Attridge and Stephen Bradley Saad in 1850 and is headquartered in Durban, South Africa.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange ASPEN PHARMACARE H. NEW stocks are traded under the ticker LDZA.
We've gathered analysts' opinions on ASPEN PHARMACARE H. NEW future price: according to them, LDZA price has a max estimate of 12.30 EUR and a min estimate of 9.82 EUR. Watch LDZA chart and read a more detailed ASPEN PHARMACARE H. NEW stock forecast: see what analysts think of ASPEN PHARMACARE H. NEW and suggest that you do with its stocks.
LDZA reached its all-time high on Jan 26, 2015 with the price of 34.80 EUR, and its all-time low was 2.15 EUR and was reached on Oct 24, 2008. View more price dynamics on LDZA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Yes, you can track ASPEN PHARMACARE H. NEW financials in yearly and quarterly reports right on TradingView.
ASPEN PHARMACARE H. NEW is going to release the next earnings report on Mar 6, 2025. Keep track of upcoming events with our Earnings Calendar.
LDZA net income for the last half-year is 106.54 M EUR, while the previous report showed 114.47 M EUR of net income which accounts for −6.93% change. Track more ASPEN PHARMACARE H. NEW financial stats to get the full picture.
Yes, LDZA dividends are paid annually. The last dividend per share was 0.18 EUR. As of today, Dividend Yield (TTM)% is 2.01%. Tracking ASPEN PHARMACARE H. NEW dividends might help you take more informed decisions.
ASPEN PHARMACARE H. NEW dividend yield was 1.54% in 2024, and payout ratio reached 36.21%. The year before the numbers were 1.86% and 29.06% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Feb 1, 2025, the company has 9.35 K employees. See our rating of the largest employees — is ASPEN PHARMACARE H. NEW on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ASPEN PHARMACARE H. NEW EBITDA is 575.45 M EUR, and current EBITDA margin is 23.95%. See more stats in ASPEN PHARMACARE H. NEW financial statements.
Like other stocks, LDZA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ASPEN PHARMACARE H. NEW stock right from TradingView charts — choose your broker and connect to your account.